No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
501 |
4. Check minimum number of eventsNone |
501 |
5. Include endpointsNone |
501 |
6. Filter based on genotype QC (FinnGen only) |
501 |
Control definitions (FinnGen only)
- Control exclude
- H7_EYEOTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- H55-H59
- Name in latin
- Nystagmus et alii motus irregulares oculi
Similar endpoints
↥List of similar endpoints to
Nystagmus and other irregular eye movements
based on the number of shared cases.
Similar with more cases:
- Other disorders of eye and adnexa
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4714 | 2279 | 2421 |
| Only index persons | 3952 | 1959 | 1993 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | 0.07 |
| Only index persons | 0.07 | 0.07 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 25.97 | 30.97 | 21.18 |
| Only index persons | 32.97 | 36.00 | 30.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 501 | 300 | 201 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | 43.61 | 42.90 | 44.68 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 457
- Matched controls
- 4562
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
+∞
323.0
446
*
R42
ICD-10 Finland
Dizziness and giddiness
5.1
45.3
173
484
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.3
42.5
112
195
H53.2
ICD-10 Finland
Diplopia
19.1
34.5
53
31
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.6
34.3
95
174
G35
ICD-10 Finland
Multiple sclerosis
21.0
29.7
44
23
AA1AD
NOMESCO Finland
CT of head and brain
3.7
27.7
144
501
109
Kela drug reimbursment
Multiple sclerosis
23.5
26.0
37
17
XCK00
NOMESCO Finland
Perimetry
6.7
24.8
66
112
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
30.0
23.4
31
11
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
20.6
21.1
31
16
3795A
ICD-9 Finland
Other disorders of eye, Nystagmus and other irregular eye movements
+∞
21.0
20
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
21.0
119
432
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.9
20.4
71
166
H50.0
ICD-10 Finland
Convergent concomitant strabismus
18.7
19.8
30
17
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.3
19.6
77
204
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
19.8
18.9
28
15
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.8
18.8
55
105
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.8
17.5
79
236
H47.2
ICD-10 Finland
Optic atrophy
52.0
17.1
20
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.4
16.7
31
29
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.6
16.7
39
55
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.4
16.6
63
160
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
16.2
71
206
H81.2
ICD-10 Finland
Vestibular neuronitis
12.3
15.7
28
24
Q12.0
ICD-10 Finland
Congenital cataract
+∞
15.7
15
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
15.4
94
352
R27.0
ICD-10 Finland
Ataxia, unspecified
46.6
15.1
18
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.5
14.8
32
40
XA800
NOMESCO Finland
Neuropsychological investigation
5.0
14.8
48
104
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
21.9
14.8
21
10
N03AX14
ATC
levetiracetam; systemic
8.0
14.7
33
44
N29
ICPC
Neurological sympt/complt other
8.5
13.5
29
36
L03AB07
ATC
interferon beta-1a; parenteral
26.6
13.4
18
7
N03AF02
ATC
oxcarbazepine; oral
6.4
13.4
35
58
H27.0
ICD-10 Finland
Aphakia
51.4
12.9
15
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.6
12.8
37
70
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.8
12.6
54
154
L03AX13
ATC
glatiramer acetate; parenteral
25.1
12.5
17
7
H50.30
ICD-10 Finland
Intermittent esotropy
21.9
12.1
17
8
L28
ICPC
Limited function/disability (L)
2.9
12.0
79
307
Z2445
NOMESCO Finland
Psychologist
3.9
11.9
49
135
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.2
11.8
45
115
N03AE01
ATC
clonazepam; systemic
4.4
11.6
42
102
164
Kela drug reimbursment
Fingolimod
66.5
11.6
13
*
H53.1
ICD-10 Finland
Subjective visual disturbances
4.4
11.3
41
100
G91.1
ICD-10 Finland
Obstructive hydrocephalus
44.3
11.0
13
*
N17
ICPC
Vertigo/dizziness
3.2
10.9
58
196
SPAT1229
SPAT
Assessment of need for aid
3.8
10.9
47
135
353
Kela drug reimbursment
Cladribine and fingolimod
112.2
10.5
11
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.9
10.4
19
18
Z2446
NOMESCO Finland
Social worker
3.0
10.3
62
227
H52.2
ICD-10 Finland
Astigmatism
6.5
10.3
26
42
H52.1
ICD-10 Finland
Myopia
4.7
10.2
34
77
N03AX09
ATC
lamotrigine; oral
4.2
10.1
38
97
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
9.8
132
741
N99
ICPC
Neurological disease other
13.7
9.7
16
12
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.2
9.6
51
173
N03AX12
ATC
gabapentin; oral
2.5
9.4
77
340
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.0
9.4
54
193
E70.3
ICD-10 Finland
Albinism
+∞
9.4
9
*
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
+∞
9.4
9
*
N86
ICPC
Multiple sclerosis
22.2
9.4
13
6
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.9
9.4
19
22
H53.0
ICD-10 Finland
Amblyopia ex anopsia
8.0
9.2
20
26
TAB00
NOMESCO Finland
Lumbar puncture
3.6
9.2
41
122
183
Kela drug reimbursment
Lamotrigin and topiramate
11.8
9.1
16
14
N05BA09
ATC
clobazam; oral
11.0
8.8
16
15
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.6
8.8
39
115
R13
ICD-10 Finland
Dysphagia
3.7
8.8
38
110
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
8.8
64
263
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
8.7
108
579
H50.1
ICD-10 Finland
Divergent concomitant strabismus
11.9
8.6
15
13
37300
ICD-8 Finland
Strabismus, Concomitans convergens
20.4
8.5
12
6
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
8.5
71
317
N28
ICPC
Limited function/disability (N)
8.8
8.4
17
20
78112
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Nystagmus
+∞
8.3
8
*
4AA23
NOMESCO Finland
NA
+∞
8.3
8
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
11.0
8.3
15
14
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
33.9
8.1
10
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.1
8.1
16
18
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.0
8.1
21
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.0
173
1144
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
7.8
54
218
L04AA27
ATC
fingolimod; oral
45.7
7.7
9
*
H50.8
ICD-10 Finland
Other specified strabismus
45.7
7.7
9
*
R51.80
ICD-10 Finland
Headache
2.2
7.7
80
396
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
7.7
64
285
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
5.1
7.7
23
47
DFF59
NOMESCO Finland
Other assessment of balance
12.1
7.6
13
11
N18
ICPC
Paralysis/weakness
6.3
7.6
19
31
M03BX01
ATC
baclofen; systemic
6.3
7.6
19
31
L04AA31
ATC
teriflunomide; oral
25.4
7.6
10
*
G44.2
ICD-10 Finland
Tension-type headache
2.4
7.4
67
310
H46
ICD-10 Finland
Optic neuritis
11.1
7.3
13
12
A28
ICPC
Limited function/disability NOS
2.4
7.3
64
292
Z31.5
ICD-10 Finland
Genetic counselling
3.1
7.2
38
129
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.0
7.2
22
46
N03AG01
ATC
valproic acid; systemic, rectal
3.1
7.2
39
135
DFF00
NOMESCO Finland
Pure tone audiometry
2.9
7.2
43
159
Z3226
NOMESCO Finland
Physiotherapist
2.0
7.1
97
538
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
12.3
7.1
12
10
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
12.3
7.1
12
10
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.0
7.1
14
16
N03AX11
ATC
topiramate; oral
5.1
7.0
21
43
R4120
NOMESCO Finland
Occupational therapy
2.9
6.8
40
147
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
40.6
6.8
8
*
R3120
NOMESCO Finland
Training in mobility skills
40.6
6.8
8
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
6.7
35
119
3503
FHL
Single muscle retroposition
22.8
6.7
9
*
H57.1
ICD-10 Finland
Ocular pain
6.6
6.7
16
25
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
12.5
6.6
11
9
N03AX18
ATC
lacosamide; systemic
12.5
6.6
11
9
R53
ICD-10 Finland
Malaise and fatigue
2.0
6.6
90
500
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.3
6.5
31
99
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
70.6
6.4
7
*
CE2W4
NOMESCO Finland
Eye movement mapping
70.6
6.4
7
*
N06AX11
ATC
mirtazapine; oral
1.8
6.4
130
829
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
+∞
6.3
6
*
H54.0
ICD-10 Finland
Blindness, binocular
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
1.8
6.2
121
759
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
27.0
6.2
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.2
96
558
R1250
NOMESCO Finland
Evaluation of functional capability
4.6
6.2
20
45
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
6.2
64
316
N06AX16
ATC
venlafaxine; oral
2.2
6.1
65
324
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
12.7
6.1
10
8
F83
ICD-10 Finland
Mixed specific developmental disorders
5.3
6.1
17
33
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
10.2
6.1
11
11
H52.0
ICD-10 Finland
Hypermetropia
4.7
6.0
19
42
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
6.0
48
209
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044290) Cell count panel - Cerebral spinal fluid
50
89
6.13
27.48
1.8
2.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
197
1016
2.55
21.72
2.5
2.1
u/l
216.1
251.3
0.16
187
962
(3016018) Differential panel - Cerebral spinal fluid
29
42
7.26
19.28
2.1
3.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
27
38
7.45
18.39
2.7
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
20
19
10.92
18.32
1.1
1.4
nmol/l
129.6
140.5
0.32
20
19
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
22
9.92
17.99
2.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
279
1823
2.20
16.44
9.1
8.3
mmol/l
1.2
1.2
0.77
237
1566
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
97
4.39
15.39
1.8
2.3
e6/l
17.3
6.4
0.62
29
73
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
97
4.39
15.39
1.9
2.4
e6/l
203.0
158.0
0.08
29
76
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
31
7.37
14.93
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
26
44
6.18
14.92
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
46
5.90
14.27
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
95
423
2.54
13.56
1.9
2.2
nmol/l
364.8
375.2
0.19
87
399
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
252
1683
2.00
12.91
8.8
8.2
mmol/l
1.2
1.2
0.11
227
1540
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
16
5
32.96
12.64
3.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
12
11.09
12.00
1.2
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
12
11.09
12.00
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29
68
4.46
11.63
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
27
6.88
11.53
1.1
1.0
u/l
0.9
1.1
—
10
14
(3013826) Glucose [Moles/volume] in Serum or Plasma
303
2216
1.93
11.30
6.1
5.7
mmol/l
6.4
6.6
0.72
280
2040
(3032080) INR in Blood by Coagulation assay
204
1314
1.93
11.17
10.5
7.5
inr
1.1
1.2
0.57
49
406
(3024561) Albumin [Mass/volume] in Serum or Plasma
229
1540
1.90
10.94
5.6
5.4
g/l
35.8
36.2
0.54
204
1441
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
388
3110
2.10
10.84
3.9
3.9
pmol/l
14.6
14.6
0.16
355
2868
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
12
10.22
10.47
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
295
2172
1.87
10.42
7.9
6.4
e9/l
2.0
2.0
0.25
258
1917
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
42
5.17
10.12
1.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
286
2104
1.84
9.93
8.0
6.4
e9/l
0.6
0.6
0.12
252
1811
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
13
9.43
9.90
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
280
2048
1.83
9.89
7.9
6.5
%
29.0
29.9
0.70
267
1935
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
5
26.61
9.85
1.1
2.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
211
1417
1.84
9.85
7.8
6.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
278
2033
1.82
9.79
7.8
6.3
%
56.9
55.4
1.23
266
1925
(3006315) Basophils [#/volume] in Blood
286
2114
1.82
9.68
8.0
6.4
e9/l
0.0
0.0
0.45
251
1822
(3023410) Appearance of Cerebral spinal fluid
23
52
4.59
9.64
2.3
3.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
23
6.69
9.39
1.1
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
267
1948
1.79
9.30
6.6
6.4
umol/l
13.0
13.5
0.12
250
1842
(3019069) Monocytes/100 leukocytes in Blood
271
1987
1.79
9.27
8.2
6.7
%
8.4
8.4
0.05
259
1877
(3013650) Neutrophils [#/volume] in Blood by Automated count
315
2418
1.81
9.20
10.0
9.4
e9/l
4.0
4.0
0.09
276
2091
(3013115) Eosinophils [#/volume] in Blood
291
2184
1.79
9.15
8.5
6.8
e9/l
0.2
0.2
0.17
256
1912
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
172
1110
1.84
8.95
2.9
2.5
u/l
53.9
54.9
0.16
158
1030
(3022096) Basophils/100 leukocytes in Blood
263
1927
1.77
8.88
8.0
6.6
%
0.7
0.7
0.05
251
1811
(3012095) Magnesium [Moles/volume] in Serum or Plasma
104
575
2.02
8.57
5.1
5.5
mmol/l
0.8
0.8
0.39
99
547
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
13
8.63
8.49
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
26
5.91
8.37
1.1
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
266
1979
1.73
8.31
8.1
6.5
%
2.7
2.8
0.50
255
1856
(3026008) Bacteria identified in Urine by Culture
163
1059
1.80
8.16
3.5
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
429
3697
2.11
8.07
5.0
4.5
mu/l
1.8
2.2
0.55
399
3429
(3026782) Osmolality of Urine
125
751
1.88
8.04
3.7
2.7
mosm/kgh2o
569.4
569.0
0.00
110
638
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
221
1594
1.69
7.49
3.2
2.5
nmol/l
79.2
75.0
1.27
207
1452
(3019309) Folate [Moles/volume] in Red Blood Cells
99
563
1.94
7.47
2.0
1.7
nmol/l
972.5
1202.1
1.96
77
426
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
194
1356
1.70
7.36
2.3
1.8
pmol/l
97.6
97.0
0.06
119
695
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
46
4.25
7.33
2.6
2.1
e6/l
807.4
763.6
—
9
16
(3002032) Base excess in Venous blood by calculation
77
403
2.08
7.32
7.5
7.1
mmol/l
2.0
1.5
0.79
71
310
(3011412) CD3 cells [#/volume] in Blood
22
60
3.79
7.26
2.7
2.8
e9/l
1.2
1.6
0.53
11
27
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1361
1.69
7.23
4.8
3.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
127
791
1.81
7.20
1.7
1.5
nmol/l
20.0
21.5
0.50
113
680
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
66
3.60
7.07
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
45
192
2.48
6.93
1.9
2.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
70
361
2.09
6.91
7.0
6.9
kpa
4.9
4.9
0.07
70
350
(3021447) Carbon dioxide [Partial pressure] in Venous blood
76
408
2.02
6.73
7.5
7.0
kpa
6.0
5.8
1.67
76
395
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
18
6.22
6.45
1.1
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
91
530
1.88
6.34
9.5
7.8
mmol/l
1.1
1.1
0.27
83
502
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
47
3.93
6.31
2.2
3.1
%
14.1
8.2
1.64
11
35
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
15
34
4.52
6.27
1.0
3.3
umol/l
29.7
26.8
0.49
15
34
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
26
5.10
6.25
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
1225
1.64
6.20
3.3
3.1
mmol/l
2.4
2.4
0.18
150
1084
(3019550) Sodium [Moles/volume] in Serum or Plasma
452
4067
2.13
6.12
20.7
13.7
mmol/l
139.5
139.6
0.73
440
3955
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1327
1.62
6.10
3.9
3.4
u/l
28.0
30.9
1.11
175
1267
(3018418) pH of Serum or Plasma
152
1043
1.66
5.95
4.6
3.9
ph
7.4
7.4
0.02
26
198
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
187
2.36
5.92
1.7
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
452
4080
2.10
5.86
20.7
13.8
mmol/l
3.9
4.0
0.69
437
3959
(21494815) CD4 cells/100 lymphocytes in Specimen
19
55
3.55
5.78
2.2
2.7
%
47.4
39.4
—
5
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
7
13.06
5.60
1.2
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
153
1068
1.62
5.54
4.4
3.1
e6/l
0.5
0.4
0.19
120
778
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
415
3668
1.76
5.42
4.5
4.0
mmol/l
5.8
5.8
0.10
382
3389
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
18
5.65
5.34
1.3
1.1
miu/ml
1869.7
1709.4
—
10
18
(3018095) Leukocytes [#/volume] in Urine
187
1381
1.56
5.29
5.2
3.8
e6/l
68.4
61.6
0.09
136
938
(3013707) Erythrocyte sedimentation rate by Westergren method
346
2935
1.58
5.17
4.2
4.0
mm/h
9.6
10.7
1.11
321
2705
(4027681)
13
31
4.28
5.11
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
117
2.57
5.05
2.0
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
326
2738
1.54
5.00
4.1
3.2
u/l
42.6
42.1
0.05
306
2588
(3002582) Erythrocytes [#/volume] in Urine
162
1170
1.57
5.00
4.4
3.2
e6/l
36.9
106.0
0.62
131
876
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
139
970
1.60
4.96
2.4
2.2
mg/l
3.3
2.9
0.47
121
837
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
99
636
1.69
4.89
3.9
2.8
e6/l
0.8
0.9
0.01
55
347
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
54
288
1.98
4.86
2.4
2.3
—
25.1
—
0
13
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
290
1.97
4.77
6.6
5.0
ng/l
98.1
72.4
1.06
46
267
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
53
284
1.97
4.71
7.7
7.3
mmol/l
24.2
24.0
0.25
48
269
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
26
103
2.61
4.70
2.2
2.0
ug/l
180.1
278.0
0.74
26
93
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
342
2922
1.54
4.69
8.4
7.0
u/l
82.5
83.6
0.14
321
2744
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
564
1.70
4.61
1.9
1.9
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
5
14.16
4.58
1.3
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
116
790
1.61
4.54
3.0
2.6
e6/l
4.4
6.2
0.76
103
689
(3000991) Gas panel - Venous blood
66
385
1.82
4.54
10.8
11.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
72
435
1.76
4.41
6.4
8.9
mmol/l
104.7
104.3
0.31
72
423
(3023368) Bacteria identified in Blood by Culture
130
916
1.57
4.40
4.2
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
147
1065
1.54
4.39
4.4
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
320
2721
1.49
4.28
6.5
4.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
7
6
11.80
4.28
1.4
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
6
11.80
4.28
1.3
1.5
—
—
—
0
0
(3013512) EKG study
136
974
1.54
4.27
3.8
3.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
88
572
1.65
4.13
3.3
2.4
umol/l
12.2
13.8
1.23
81
531
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
132
946
1.54
4.11
2.6
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
68
413
1.75
4.10
6.8
5.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
448
4126
1.81
4.08
18.4
12.1
mg/l
21.5
21.9
0.09
359
3149
(3007853) Bacteria identified in Skin by Aerobe culture
78
493
1.69
4.07
2.9
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
92
608
1.63
4.05
4.3
2.9
e6/l
2.1
2.4
0.15
49
320
(3044640) Blood type and Crossmatch panel - Blood
163
1227
1.49
4.01
2.6
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
106
2.43
3.96
1.7
2.3
g/l
3.3
3.1
0.23
17
85
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
654
1.60
3.93
3.8
3.7
ng/l
114.9
606.9
1.75
74
457
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
82
2.63
3.93
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
82
2.63
3.93
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
103
706
1.58
3.89
1.7
1.6
pmol/l
469.9
444.6
0.43
87
603
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
114
2.35
3.84
1.7
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
114
2.35
3.84
1.7
2.2
g/l
3.5
3.7
0.54
17
84
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
114
2.35
3.84
1.7
2.2
g/l
7.2
7.2
0.01
17
89
(3013336) Amino acids [Identifier] in Serum or Plasma
7
8
8.85
3.78
1.4
3.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
5
12.12
3.77
1.2
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
103
2.40
3.72
1.3
2.3
g/l
9.0
10.3
1.29
18
92
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
16
5.70
3.67
3.3
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
164
2.08
3.63
2.2
1.8
u/l
9.2
8.8
0.06
21
126
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
226
1840
1.41
3.57
3.8
4.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
46
3.10
3.55
2.2
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
461
4313
1.86
3.55
12.4
9.4
u/l
25.3
26.3
0.76
449
4169
(3035637) Corticotropin [Mass/volume] in Plasma
18
69
2.67
3.50
1.9
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
6
10.10
3.50
1.0
1.2
umol/l
17.8
18.3
—
6
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
126
2.21
3.48
2.1
1.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
271
1.81
3.39
4.6
3.7
mmol/l
1.2
1.2
0.22
37
239
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
250
1.83
3.32
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
218
0.31
3.28
1.4
1.5
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
6
7
8.65
3.27
1.8
1.1
umol/l
97.7
90.6
—
6
7
(3001122) Ferritin [Mass/volume] in Serum or Plasma
228
1880
1.39
3.25
3.3
2.8
ug/l
144.3
98.6
0.62
213
1756
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
11
6.43
3.19
1.1
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
65
419
1.63
3.16
2.5
3.5
%
1.8
1.7
0.52
58
385
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
74
493
1.59
3.14
3.4
2.5
%
19.8
23.6
2.00
65
432
(3009508) Creatinine [Moles/volume] in Urine
145
1111
1.43
3.14
3.7
3.4
mmol/l
7.7
7.9
0.19
132
947
(3022217) INR in Platelet poor plasma by Coagulation assay
59
372
1.66
3.12
20.1
16.7
inr
1.6
1.2
—
5
63
(21494814) CD8 cells/100 lymphocytes in Specimen
7
12
5.89
3.03
2.0
2.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
161
1264
1.40
3.03
3.5
3.2
ng/l
40.0
30.4
0.25
112
766
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
62
400
1.63
3.01
1.7
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
532
1.55
3.00
3.2
2.4
g/l
2.4
2.4
0.23
71
495
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
119
886
1.45
3.00
3.2
3.6
ng/l
1278.4
1071.7
0.27
103
739
(3021589) Normoblasts [#/volume] in Blood
228
1898
1.37
3.00
10.1
9.3
e9/l
0.0
0.0
0.55
184
1519
(3052851) Hemolysis interference index of Serum or Plasma
23
108
2.18
2.95
3.3
3.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
21
95
2.26
2.93
4.2
3.8
umol/l
29.8
36.1
0.80
21
82
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
209
1.83
2.87
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
96
2.24
2.87
3.4
10.7
u/ml
0.6
0.4
0.71
11
50
(3023520) Reticulocytes [#/volume] in Blood
49
301
1.70
2.87
2.7
3.2
e9/l
74.7
69.7
0.31
39
222
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
53
2.69
2.81
1.5
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
79
549
1.52
2.79
1.3
1.4
titre
583.5
445.1
0.37
17
110
(3044927) Protein electrophoresis panel - Urine
10
31
3.27
2.78
1.3
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
6
8.40
2.75
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
6
8.40
2.75
1.2
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
47
289
1.69
2.75
10.5
8.0
—
—
—
0
0
(3019225) pH of Specimen
50
313
1.66
2.73
6.7
4.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
85
603
1.49
2.73
2.9
2.5
mmol/l
2.5
2.4
1.24
70
528
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
10
6.05
2.70
1.0
1.0
mg/g
5.7
5.1
—
6
10
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
380
3460
1.41
2.70
5.6
5.0
mmol/mol
37.9
39.0
1.69
347
3239
(40768797) Stomach Pathology biopsy report
73
504
1.52
2.66
1.2
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
43
2.83
2.66
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
128
986
1.40
2.65
1.7
1.5
g/l
2.1
2.2
0.29
83
578
(3015171) Extractable nuclear Ab [Units/volume] in Serum
26
134
1.99
2.65
1.2
1.4
—
1.9
—
0
6
(40761511) CBC panel - Blood by Automated count
455
4296
1.64
2.64
17.2
11.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
278
1.68
2.59
4.5
4.9
%
0.4
0.4
—
9
70
(3043409) Potassium [Moles/volume] in Arterial blood
20
94
2.17
2.58
5.9
3.8
mmol/l
4.1
3.9
0.75
20
82
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
62
2.46
2.56
1.5
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
11
5.50
2.55
1.2
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
11
5.50
2.55
1.2
6.9
—
—
—
0
0
(3015736) pH of Urine
184
1517
1.34
2.46
4.9
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
60
404
1.55
2.45
1.8
1.9
—
—
—
0
0
(3010421) pH of Blood
18
83
2.21
2.43
3.3
3.1
ph
7.4
7.4
0.12
13
71
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
397
3667
1.40
2.38
3.9
3.6
mmol/l
1.3
1.3
0.69
366
3418
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
391
3603
1.39
2.38
14.4
10.6
ml/min/173m2
88.3
87.0
0.49
330
2878
(3011397) Hemoglobin [Presence] in Urine by Test strip
116
895
1.38
2.36
4.9
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
411
3823
1.42
2.33
4.4
4.0
mmol/l
4.5
4.7
2.65
378
3578
(3024731) MCV [Entitic volume]
483
4658
2.02
2.30
27.0
17.8
fl
90.2
90.0
0.31
478
4599
(3035941) MCH [Entitic mass]
483
4660
2.00
2.27
26.9
17.8
pg
30.1
30.1
0.12
478
4600
(3026361) Erythrocytes [#/volume] in Blood
483
4661
2.00
2.25
27.0
17.9
e12/l
4.5
4.5
0.26
470
4503
(40760888) Immunoglobulin light chains.free panel - Serum
14
60
2.37
2.23
3.6
4.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
507
0.59
2.23
1.3
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
9
5.60
2.21
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
483
4663
1.99
2.21
27.1
17.9
e9/l
6.9
6.7
0.84
471
4505
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
352
1.53
2.10
10.5
8.0
mmol/l
1.2
1.1
0.01
41
267
(3007461) Platelets [#/volume] in Blood
482
4657
1.91
2.09
27.1
17.9
e9/l
255.7
256.7
0.11
469
4516
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
239
1.64
2.08
1.9
1.6
iu/l
24.5
24.2
0.01
26
197
(3025159) Blasts/100 leukocytes in Blood
42
271
1.60
2.08
5.4
5.3
%
0.0
0.1
—
10
78
(3020961) Endomysium IgA Ab [Titer] in Serum
41
263
1.61
2.08
1.2
1.1
—
12.6
—
0
8
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
626
0.64
2.06
1.4
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
322
0.51
2.03
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
104
1.96
2.03
1.5
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
44
2.53
2.02
10.6
14.7
%
12.0
11.9
0.02
11
44
(3035350) Ketones [Presence] in Urine by Test strip
223
1927
1.28
2.02
5.3
3.4
estimate
0.0
0.0
0.00
45
374
(3020891) Body temperature
23
127
1.85
1.97
6.8
5.2
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
7
21
3.36
1.97
2.3
2.7
nmol/l
0.1
0.1
—
7
15
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
21
3.36
1.97
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
157
1.76
1.96
5.1
4.8
g/l
0.2
0.3
0.07
17
81
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
425
1.47
1.96
4.5
4.1
%
29.3
31.8
1.50
42
290
(3008536) Aspergillus sp Ab [Presence] in Serum
5
11
4.58
1.94
1.4
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
132
1069
1.32
1.94
6.1
7.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
58
2.27
1.92
1.8
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
115
915
1.33
1.91
3.7
3.3
mg/l
1552.7
350.2
0.78
81
609
(3003396) Base excess in Arterial blood by calculation
52
360
1.50
1.91
8.2
11.4
mmol/l
0.7
1.0
0.16
43
284
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
22
3.21
1.88
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
22
122
1.84
1.87
1.8
1.7
—
266.7
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
6
17
3.56
1.84
2.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
120
966
1.32
1.84
4.5
4.0
mg/mmol
5.5
9.0
0.93
82
635
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
248
1.58
1.82
1.7
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
221
1926
1.26
1.82
7.5
4.7
estimate
0.0
0.0
0.50
45
386
(3044889) 12 lead EKG panel
280
2510
1.26
1.80
3.8
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
45
306
1.52
1.80
5.4
5.0
%
0.7
0.8
0.26
12
100
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
333
1.49
1.75
1.3
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
24
2.94
1.72
1.9
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
404
3800
1.32
1.71
4.4
4.0
mmol/l
1.4
1.5
1.90
373
3548
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
410
3865
1.33
1.70
4.8
4.4
mmol/l
2.7
2.8
2.04
377
3599
(3049717) Cytology report of Urine Cyto stain
19
104
1.86
1.69
2.0
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
62
2.13
1.66
1.2
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
42
288
1.50
1.63
5.7
5.1
%
0.3
0.2
—
10
91
(40761535) Cells panel - Urine sediment
42
288
1.50
1.63
3.8
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
56
2.17
1.62
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
167
1.65
1.61
2.4
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
6
20
3.02
1.58
1.0
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
24
146
1.68
1.53
2.2
1.6
g/l
1.2
1.2
0.21
24
141
(3009261) Glucose [Presence] in Urine by Test strip
221
1954
1.23
1.53
5.3
3.5
estimate
0.0
0.0
0.50
42
372
(3012501) Base excess in Blood by calculation
14
72
1.97
1.50
3.6
3.3
mmol/l
2.2
2.4
—
7
43
(3019832) Treponema pallidum Ab [Presence] in Serum
43
596
0.70
1.49
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
1003
1.27
1.47
1.7
1.7
mmol/l
1.4
1.4
0.07
109
873
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
28
2.52
1.45
2.7
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
22
2.75
1.43
2.8
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
39
2.33
1.43
1.8
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
40
2.27
1.40
1.2
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1084
1.26
1.40
1.5
1.4
u/ml
1.0
1.4
0.57
26
267
(3041354) Potassium [Moles/volume] in Venous blood
9
41
2.22
1.37
1.8
2.8
mmol/l
4.4
4.0
—
9
41
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
41
2.22
1.37
1.8
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
41
2.22
1.37
1.8
2.8
mmol/l
106.8
106.4
—
9
41
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
536
1.33
1.36
1.7
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
68
1.94
1.34
1.2
1.1
u/ml
5.0
2.5
—
7
30
(3009542) Hematocrit [Volume Fraction] of Blood
413
3932
1.28
1.33
20.0
13.6
%
40.4
40.1
0.36
285
3120
(3019060) Gas panel - Arterial blood
29
193
1.53
1.32
5.2
7.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
69
1.91
1.29
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
107
890
1.26
1.27
2.1
2.3
mg/l
1.4
1.2
0.32
79
681
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
348
1.39
1.26
4.1
3.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
37
2.18
1.22
1.1
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
86
1.77
1.20
8.8
10.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
17
102
1.69
1.17
1.3
1.3
—
64.3
—
0
7
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
152
0.52
1.16
1.6
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
66
524
1.30
1.14
2.0
2.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
80
1.77
1.14
3.1
3.5
e9/l
5.8
4.2
0.35
14
80
(4035726)
41
303
1.38
1.13
1.4
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.02
1.12
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
40
2.02
1.12
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.02
1.12
1.1
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
381
3618
1.22
1.11
21.7
15.1
%
13.6
13.5
0.58
371
3556
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
81
1.75
1.10
3.1
3.7
%
61.5
56.5
0.70
14
81
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
41
1.97
1.09
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
180
0.55
1.09
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
180
0.55
1.09
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
180
0.55
1.09
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
180
0.55
1.09
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
147
0.54
1.05
1.5
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
149
0.53
1.05
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
149
0.53
1.05
1.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
54
423
1.31
1.04
1.4
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
60
1.85
1.03
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
34
2.07
1.03
2.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
214
1.43
1.02
2.4
2.2
u/l
949.7
3216.1
—
7
84
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
110
0.45
1.01
1.4
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
35
2.01
1.00
3.0
4.6
%
100.3
95.1
—
7
35
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
431
0.72
0.98
1.4
1.6
—
—
—
0
0
(4024509)
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
52
410
1.30
0.96
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
110
946
1.21
0.96
7.0
4.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
29
2.08
0.89
1.7
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
26
186
1.42
0.89
2.7
3.0
e6/l
0.2
0.1
0.33
26
180
(3026389) Candida sp identified in Specimen by Organism specific culture
8
42
1.92
0.89
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
87
1.63
0.88
2.1
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
136
1.49
0.87
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
96
1.58
0.85
1.6
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
118
1037
1.18
0.82
5.8
3.8
estimate
0.0
0.0
0.50
43
377
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
32
1.88
0.82
1.2
1.3
—
68.0
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
406
0.75
0.82
1.7
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
47
1.71
0.81
1.4
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
96
0.52
0.79
2.8
3.4
umol/l
4.1
11.7
—
5
76
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
546
0.79
0.78
3.3
2.7
ug/l
0.6
0.7
0.42
30
327
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
166
1505
1.15
0.78
5.7
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
158
1.41
0.75
6.9
3.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
24
2.09
0.74
1.4
1.8
u/field
0.6
8.1
—
5
17
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
11.4
8.4
mmol/l
0.6
0.6
—
5
24
(3004809) Band form neutrophils/100 leukocytes in Blood
9
55
1.65
0.74
2.2
2.9
%
1.4
1.2
—
9
44
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
39
1.81
0.72
2.4
3.4
nmol/l
2.2
3.1
—
7
39
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
84
1.56
0.72
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
103
906
1.17
0.71
3.2
2.9
umol/l
2575.8
5733.5
0.59
94
798
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
57
1.59
0.71
2.6
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
126
1.44
0.71
1.9
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
144
0.62
0.70
1.3
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
79
682
1.19
0.68
1.2
1.3
iu/ml
11.7
30.4
3.69
17
209
(4198724)
5
27
1.86
0.68
2.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
2.9
u/ml
16829.8
743.8
—
5
27
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
5
27
1.86
0.68
1.4
1.3
e6/l
1252.8
4492.2
—
5
16
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
190
0.68
0.66
1.5
1.5
—
—
—
0
0
(4146454)
5
28
1.79
0.66
2.4
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
44
1.60
0.65
1.1
1.3
nmol/l
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
129
0.61
0.64
1.5
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
146
1.38
0.64
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
95
1.49
0.64
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
112
1.44
0.64
1.4
1.4
ug/g
227.7
337.0
—
8
60
(4281824)
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
164
1.36
0.63
2.3
2.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
1.0
1.0
g/l
1.6
1.4
—
8
44
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
30
1.67
0.61
1.4
1.6
—
—
—
0
0
(4062490)
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
50
1.61
0.61
1.4
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
0
20
0.00
0.60
0.0
5.2
—
7.4
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
4.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
52
1.55
0.59
1.1
1.3
nmol/l
0.7
0.5
—
8
45
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
42
347
1.23
0.58
5.8
3.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
35
1.72
0.58
1.5
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
176
1.32
0.57
2.4
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
53
451
1.20
0.55
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
222
1.28
0.55
3.7
2.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
126
1.36
0.52
2.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
335
0.79
0.52
1.2
1.3
iu/ml
92.5
139.3
—
10
136
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
475
1.18
0.50
4.5
3.6
umol/l
7.4
7.6
0.04
37
411
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
311
0.79
0.49
1.6
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
108
0.64
0.49
2.6
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
128
1.34
0.48
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
102
1.38
0.47
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
254
0.78
0.47
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
119
1093
1.12
0.46
5.0
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
164
0.72
0.46
1.5
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
1.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
86
1.40
0.44
9.1
4.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
166
1555
1.10
0.44
2.1
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
95
1.38
0.44
1.5
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
56
1.43
0.42
3.1
3.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
56
1.43
0.42
2.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
15
195
0.76
0.42
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
32
1.57
0.42
1.8
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
59
1.36
0.41
1.4
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
79
1.40
0.41
1.6
3.9
mg/l
25.0
28.2
—
5
50
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(4010399)
31
260
1.20
0.40
1.7
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
24.8
17.5
nmol/l
1126.6
1443.7
—
5
35
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
124
1.30
0.39
1.0
1.2
u/ml
0.4
3.7
—
10
67
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
67
1.35
0.38
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
170
1.25
0.37
1.4
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
202
0.78
0.37
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
143
1.27
0.37
1.2
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
5
37
1.35
0.37
3.0
2.3
%
63.4
57.7
—
5
27
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
537
1.13
0.36
2.0
1.8
%
1.8
1.4
1.44
53
480
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
308
0.84
0.35
1.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
190
1.22
0.35
1.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
43
1.40
0.35
1.7
1.2
—
—
—
0
0
(4268621)
6
44
1.37
0.34
2.7
2.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
44
1.37
0.34
1.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
91
1.33
0.34
2.6
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
92
994
0.91
0.34
1.9
1.9
—
—
—
0
0
(4306422)
7
56
1.25
0.29
1.1
1.2
—
—
—
0
0
(4034850)
10
129
0.77
0.28
5.3
8.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
64
586
1.11
0.28
2.2
2.7
ug/g
132.7
105.4
0.29
54
468
(1616796) Gas panel - Central venous blood
10
76
1.32
0.28
3.9
3.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
62
1.29
0.28
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
290
1.15
0.27
2.1
2.6
ml/min/173m2
84.5
71.0
0.88
13
120
(44790048)
8
66
1.22
0.27
1.4
2.0
—
—
—
0
0
(44790049)
8
66
1.22
0.27
1.4
2.0
—
—
—
0
0
(44806118)
8
66
1.22
0.27
1.4
2.0
—
—
—
0
0
(44790047)
8
66
1.22
0.27
1.4
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
142
1490
0.93
0.26
2.7
2.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
26
225
1.16
0.26
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
73
0.68
0.26
5.8
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
73
1.24
0.25
1.2
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
1.2
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
318
0.87
0.25
4.2
3.9
ug/l
2.7
21.1
0.75
21
257
(4094501)
6
85
0.70
0.24
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
275
1.14
0.23
4.1
2.3
e9/l
4.8
4.2
0.44
25
227
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
86
808
1.08
0.23
1.8
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
39
1.28
0.23
4.4
2.9
u/ml
18.8
58.8
—
5
39
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
88
1.26
0.22
1.3
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
91
858
1.07
0.22
5.7
3.6
kg/l
1.0
1.0
0.37
14
120
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
267
1.13
0.22
1.1
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
107
1.22
0.21
1.6
1.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.4
—
2.7
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
101
0.79
0.21
2.0
1.7
—
105.9
—
0
17
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
1.9
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
13.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
13.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
89
1.24
0.21
2.0
1.8
pmol/l
160.0
227.5
1.37
11
84
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
654
0.92
0.21
1.3
1.3
u/ml
1.3
6.7
2.73
23
261
(3028707) Methadone [Presence] in Urine by Screen method
14
117
1.20
0.20
2.7
2.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
14
0.00
0.20
0.0
3.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
146
1.17
0.19
1.8
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
75
710
1.07
0.17
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.3
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
67
0.74
0.17
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
76
0.79
0.15
2.0
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
371
1.08
0.15
2.5
2.2
u/l
28.2
32.2
0.57
31
314
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
129
0.85
0.15
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
88
0.79
0.14
1.6
1.3
—
31.1
—
0
10
(3045414) Leukocytes [Presence] in Urine
17
150
1.14
0.14
1.2
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
84
1.19
0.14
1.0
1.1
iu/ml
1.0
27.3
—
5
23
(3000492) Spirometry study
41
383
1.08
0.13
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
468
0.93
0.13
1.7
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
67
700
0.95
0.12
2.2
2.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
191
1.10
0.12
10.7
14.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
101
1042
0.96
0.11
1.7
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
47
447
1.06
0.10
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
45
1.11
0.10
1.6
4.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
45
1.11
0.10
1.6
2.9
ug/l
15.6
21.0
—
5
45
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
145
1.11
0.09
1.4
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
116
1.12
0.09
1.3
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
121
1239
0.97
0.09
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
3.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
55
1.09
0.09
3.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
26
243
1.07
0.09
1.2
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
56
1.07
0.08
3.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
56
1.07
0.08
3.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
56
1.07
0.08
3.0
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
723
0.96
0.08
4.0
4.1
%
23.1
21.4
0.30
25
321
(3025941) Bacteria identified in Stool by Culture
25
234
1.07
0.08
1.4
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
7
64
1.09
0.08
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
66
1.06
0.08
1.6
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
1.2
1.3
ug/l
2.0
3.4
—
6
64
(3028300) Cannabinoids [Presence] in Urine
22
235
0.93
0.07
2.3
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
75
1.07
0.07
1.9
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
6.9
3.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
83
0.84
0.07
2.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.2
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
91
0.88
0.07
2.1
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
132
0.91
0.06
1.2
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
128
1.10
0.06
2.1
1.8
nmol/l
51.1
35.4
1.18
14
122
(40768793) Breast Pathology biopsy report
9
104
0.86
0.06
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
233
0.94
0.06
2.3
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
232
0.95
0.05
2.3
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
110
1.09
0.05
1.4
1.6
u/ml
284.2
193.0
—
5
59
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
635
0.97
0.05
2.2
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
130
0.92
0.04
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
231
0.95
0.04
1.9
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
93
914
1.02
0.04
4.4
4.5
ug/l
1.6
2.4
1.26
87
821
(40768443) Skin Pathology biopsy report
16
152
1.05
0.02
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
113
1.06
0.01
1.4
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
104
1.06
0.00
1.7
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
165
1.03
0.00
1.3
1.4
miu/ml
263.9
267.9
—
7
87
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
188
1.01
0.00
2.2
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
313
3125
1.00
0.00
3.1
3.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
222
0.99
0.00
2.3
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
69
0.87
0.00
1.2
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
64
0.94
0.00
3.5
2.5
u/ml
4.1
12.2
—
6
57
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
1.4
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
2.6
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
51
0.98
0.00
4.8
10.4
mmol/l
5.9
6.5
—
5
44
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.3
—
9130.0
—
0
6
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
52
0.96
0.00
1.6
1.3
—
30.1
—
0
5
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
3.4
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
23.5
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
38.4
—
0
7
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_NYSTAGMUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_NYSTAGMUS | 1.772 [1.39, 2.25] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.166 |
During the follow-up period (1.1.1998 — 31.12.2019), 175 out of 1946 females with H7_NYSTAGMUS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_NYSTAGMUS | 2.021 [1.62, 2.52] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 210 out of 2046 males with H7_NYSTAGMUS died.
Mortality risk
Mortality risk for people of age
years, who have H7_NYSTAGMUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.126% | 0.334% |
| 5 | 1.05% | 2.326% |
| 10 | 2.605% | 5.471% |
| 15 | 4.768% | 10.192% |
| 20 | 8.138% | 17.425% |
Relationships between endpoints
↥Index endpoint: H7_NYSTAGMUS – Nystagmus and other irregular eye movements
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data